Menu
Recruiting NCT07588971

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology

Observational Pediatric Epilepsies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Pediatric Epilepsies. Basic parameters: up to 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Natural History and Prognosis of Pediatric Epilepsies With Different Etiology: Long-term Study

Overview

Epilepsy is one of the most common neurological diseases in Italy, affecting about 500,000 people. Pediatric age represents one of the most affected groups with a consequent significant impact on the quality of life of the families involved. The study aims to monitor the cognitive functions of patients followed at our center in order to determine the main types of pathways and highlight their determinants. The ultimate goal is to define what are the main clinical and instrumental predictors of cognitive function and its variation over time.

Primary outcome measures

  • neurodevelopment level [Time frame: 12 months after entry visit]
Secondary outcome measures (3)
  • Seizure outcome [Time frame: 24 months after entry visit]
  • QOLIE-31 [Time frame: 24 months after entry visit]
  • Clinical Global Impression Scale [Time frame: 24 months after entry visit]

Eligibility criteria

Inclusion criteria

  • Patients seen at the Children's Neuropsychiatry of the Fondazione Policlinico Gemelli IRCCS (UOS Diagnosis and Treatment of Drug-Resistant Epilepsies, Day Hospital or inpatient setting at the Department of Children's Neuropsychiatry) with onset of first seizure between the ages of 0 and 18 years and subsequent diagnostic confirmation of epilepsy (2 or more unprovoked seizures at least 24 hours apart or definite epilepsy syndrome, with diagnostic confirmation by the child neuropsychiatrist).
  • Patients already followed at Child Neuropsychiatry with a diagnosis of epilepsy with age of onset between 0 and 18 years.
  • Patients referred to our Center during follow-up with a diagnosis of epilepsy with age of onset between 0 and 18 years.

Exclusion criteria

  • Patients with unconfirmed diagnosis of epilepsy after the first critical episode.
  • Patients from other Centers, for whom the history, clinical and instrumental data are not sufficiently detailed and in accordance with the methodologies followed at our Center.
  • Patients with follow-up < 2 years.
  • Patients for whom study consent is not provided.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Italy · 1 center
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Rome

Identifiers

NCT: NCT07588971 · 3971

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗